502925-04-4 Usage
Uses
Used in Pharmaceutical Industry:
(4S,5R)-4-(tert-Butyl-dimethyl-silanyloxymethyl)-5-((Z)-pentadec-3-enyl)-2-phenyl-4,5-dihydro-oxazole is used as a potential pharmaceutical candidate for its possible biological activity. (4S,5R)-4-(tert-Butyl-dimethyl-silanyloxymethyl)-5-((Z)-pentadec-3-enyl)-2-phenyl-4,5-dihydro-oxazole's unique structure and chirality may allow it to interact with biological targets in novel ways, making it a promising candidate for the development of new drugs.
Used in Materials Science:
In the field of materials science, (4S,5R)-4-(tert-Butyl-dimethyl-silanyloxymethyl)-5-((Z)-pentadec-3-enyl)-2-phenyl-4,5-dihydro-oxazole may be utilized as a component in the synthesis of advanced materials. Its silicon-containing nature and complex structure could contribute to the development of new materials with unique properties.
Used in Organic Synthesis:
(4S,5R)-4-(tert-Butyl-dimethyl-silanyloxymethyl)-5-((Z)-pentadec-3-enyl)-2-phenyl-4,5-dihydro-oxazole can also be used as a synthetic intermediate in organic synthesis. Its complex structure and functional groups make it a valuable building block for the creation of other complex molecules, potentially leading to new compounds with various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 502925-04-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,2,9,2 and 5 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 502925-04:
(8*5)+(7*0)+(6*2)+(5*9)+(4*2)+(3*5)+(2*0)+(1*4)=124
124 % 10 = 4
So 502925-04-4 is a valid CAS Registry Number.
502925-04-4Relevant academic research and scientific papers
Stereoselective synthesis of D-erythro- and L-threo-sphinganines via palladium-catalyzed equilibration and Suzuki coupling
Cook, Gregory R.,Pararajasingham, Ketheeswaran
, p. 9027 - 9029 (2007/10/03)
The Pd-catalyzed isomerization of 5-vinyloxazolines was utilized for the stereoselective synthesis of D-erythro- and L-threo-spinganine triacetate. A hydroboration/Suzuki coupling sequence was employed to elongate the hydrophobic chain.
